180 related articles for article (PubMed ID: 908462)
1. On the mechanism of diazoxide-induced hyperglycemia.
Altszuler N; Moraru E; Hampshire J
Diabetes; 1977 Oct; 26(10):931-5. PubMed ID: 908462
[TBL] [Abstract][Full Text] [Related]
2. Interaction of somatostatin, glucagon, and insulin on hepatic glucose output in the normal dog.
Altszuler N; Gottlieb B; Hampshire J
Diabetes; 1976 Feb; 25(2):116-21. PubMed ID: 1248672
[TBL] [Abstract][Full Text] [Related]
3. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
Rizza RA; Cryer PE; Gerich JE
J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
[TBL] [Abstract][Full Text] [Related]
4. Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man.
Rizza RA; Cryer PE; Haymond MW; Gerich JE
J Clin Invest; 1980 Mar; 65(3):682-9. PubMed ID: 6243675
[TBL] [Abstract][Full Text] [Related]
5. The role of glucagon in the pathogenesis of the endogenous hyperglycemia of diabetes mellitus.
Sakurai H; Dobbs RE; Unger RH
Metabolism; 1975 Nov; 24(11):1287-97. PubMed ID: 1186499
[TBL] [Abstract][Full Text] [Related]
6. Effects of somatostatin and adrenergic blockade on glucagon, insulin and glucose in exercising sheep.
Brockman RP; Halvorson R
Aust J Biol Sci; 1981; 34(5-6):551-60. PubMed ID: 6122438
[TBL] [Abstract][Full Text] [Related]
7. Effect of phentolamine on the somatostatin-induced inhibition of glucagon and insulin secretion.
Kaneto A; Kajinuma H; Kaneko T; Kosaka K
Metabolism; 1978 Aug; 27(8):901-10. PubMed ID: 209286
[TBL] [Abstract][Full Text] [Related]
8. Glucose homeostasis during prolonged suppression of glucagon and insulin secretion by somatostatin.
Sherwin RS; Hendler R; DeFronzo R; Wahren J; Felic P
Proc Natl Acad Sci U S A; 1977 Jan; 74(1):348-52. PubMed ID: 264686
[TBL] [Abstract][Full Text] [Related]
9. Hyperglycemic effect of neurotensin.
Yawata Y; Yamatani K; Tominaga M; Ebitani I; Hara M; Sasaki H
Tohoku J Exp Med; 1984 Jun; 143(2):185-96. PubMed ID: 6147906
[TBL] [Abstract][Full Text] [Related]
10. Catecholamine responses and their interactions with other glucoregulatory hormones.
Vranic M; Gauthier C; Bilinski D; Wasserman D; El Tayeb K; Hetenyi G; Lickley HL
Am J Physiol; 1984 Aug; 247(2 Pt 1):E145-56. PubMed ID: 6147092
[TBL] [Abstract][Full Text] [Related]
11. Effect of alpha-adrenergic stimulation and its blockade on glucose turnover in man.
Rizza RA; Haymond MW; Miles JM; Verdonk CA; Cryer PE; Gerich JE
Am J Physiol; 1980 May; 238(5):E467-72. PubMed ID: 6990786
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion.
Campbell PJ; Bolli GB; Cryer PE; Gerich JE
N Engl J Med; 1985 Jun; 312(23):1473-9. PubMed ID: 2859524
[TBL] [Abstract][Full Text] [Related]
13. Effect of hyperglycemia independent of changes in insulin or glucagon on lipolysis in the conscious dog.
Shulman GI; Williams PE; Liljenquist JE; Lacy WW; Keller U; Cherrington AD
Metabolism; 1980 Apr; 29(4):317-20. PubMed ID: 6103495
[TBL] [Abstract][Full Text] [Related]
14. Adrenergic mechanisms of catecholamine action on glucose homeostasis in man.
Rizza RA; Cryer PE; Haymond MW; Gerich JE
Metabolism; 1980 Nov; 29(11 Suppl 1):1155-63. PubMed ID: 7001182
[TBL] [Abstract][Full Text] [Related]
15. Studies on the mechanism of epinephrine-induced hyperglycemia in man. Evidence for participation of pancreatic glucagon secretion.
Gerich JE; Lorenzi M; Tsalikian E; Karam JH
Diabetes; 1976 Jan; 25(1):65-71. PubMed ID: 1107095
[TBL] [Abstract][Full Text] [Related]
16. Phentolamine prevents the somatostatin-mediated inhibition of pancreatic glucagon secretion.
Smith PH; Woods SC; Ensinck JW; Porte D
Metabolism; 1977 Aug; 26(8):841-5. PubMed ID: 195179
[TBL] [Abstract][Full Text] [Related]
17. Relative contribution of nervous system and hormones to hyperglycemia induced by thyrotropin-releasing hormone in fed rats.
Ishiguro T; Iguchi A; Kunoh Y; Goto M; Uemura K; Miura H; Nonogaki K; Sakamoto N
Neuroendocrinology; 1991 Jul; 54(1):1-6. PubMed ID: 1681438
[TBL] [Abstract][Full Text] [Related]
18. Effect of somatostatin on neurotensin-induced glucagon release and hyperglycemia.
Ukai M; Inoue I; Itatsu T
Endocrinology; 1977 May; 100(5):1284-6. PubMed ID: 849724
[TBL] [Abstract][Full Text] [Related]
19. Effect of adrenergic drugs on glucose and plasma glucagon and insulin responses to xylazine in sheep.
Muggaberg J; Brockman RP
Res Vet Sci; 1982 Jul; 33(1):118-20. PubMed ID: 6753074
[TBL] [Abstract][Full Text] [Related]
20. Glucose disposal during insulinopenia in somatostatin-treated dogs. The roles of glucose and glucagon.
Shulman GI; Liljenquist JE; Williams PE; Lacy WW; Cherrington AD
J Clin Invest; 1978 Aug; 62(2):487-91. PubMed ID: 670404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
